VIVALDI Praxis: Valdoxan improves depressive symptoms and normalizes circadian rhythms: A prospective multicentre observational study.
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Agomelatine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- Acronyms VIVALDI-Praxis
- Sponsors Servier
- 30 Sep 2010 Actual end date (30 Sep 2010) added as reported by ISRCTN: Current Controlled Trials.
- 30 Sep 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 26 Apr 2010 New trial record